Testing and analytical service providers play a critical role in ensuring product quality, safety, and regulatory compliance across healthcare and life sciences, through advanced physicochemical characterization, analytical testing, and certification services. The segment is shaped by evolving regulatory requirements, increasing product complexity, and growing demand for high-quality, reproducible data. Adoption by pharmaceutical, medical device, and consumer health companies depends on analytical accuracy, method validation, turnaround times, and the ability to support regulatory submissions. Regulatory frameworks vary across regions, influencing accreditation standards (e.g., GMP, GLP, ISO), testing protocols, and reporting requirements. Geopolitical factors — including supply chain disruptions, trade policies, and localization requirements — further impact global laboratory networks and cross-border testing capabilities. Clients increasingly expect integrated analytical solutions and actionable insights to support product development, quality control, and lifecycle management. At the same time, competition is intensifying with the emergence of specialized laboratories, advanced instrumentation, and digital-enabled testing platforms, requiring continuous investment in technology and capabilities. Operational efficiency, laboratory scalability, and end-to-end integration of analytical workflows are essential to sustain growth, ensure compliance, and maintain profitability in a fragmented and highly competitive market.

We help testing and analytics companies address these challenges across the full spectrum of strategic and operational capabilities. 

  • Corporate Strategy: we define global ambitions, assess market opportunities across end-markets (pharma, medical devices, consumer health), prioritize service portfolios (physicochemical testing, microbiology, stability, etc.), design business models, and develop multi-year growth plans, including geographic expansion, partnerships, and alliances
  • Customer Insights: we map key stakeholders – including pharmaceutical companies, medical device manufacturers, CROs, and regulators – capture the voice of customers, and refine value propositions to improve service adoption, differentiation, and client retention
  • Commercial Strategy: we design go-to-market models, key account strategies, pricing frameworks, commercial excellence programs, and competitive benchmarking tailored to laboratory services, contract testing, and certification activities
  • Medical Affairs: we support method validation, compliance with regulatory standards (GMP, GLP, ISO), and engagement with regulatory authorities and industry bodies to strengthen credibility and ensure alignment with evolving requirements
  • Market Access: we advise on global regulatory pathways, accreditation strategies, quality standards, and compliance frameworks, as well as public affairs and industry positioning to support market entry and expansion
  • R&D and Innovation: we optimize service portfolio development, technology adoption (advanced analytical techniques, automation, digitalization), lifecycle management, and lab network capabilities to accelerate high-value testing solution 
  • M&A and Transactions: we conduct commercial and vendor due diligence of laboratory assets, define build-up strategies in fragmented TIC markets, support acquisition planning, and drive post-merger integration of lab networks and capabilities

By combining deep sector expertise with end-to-end strategic and operational support, we help testing and analytics companies accelerate growth, optimize portfolios, navigate regulatory and geopolitical complexity, strengthen adoption, and deliver measurable value to healthcare providers, payers, and patients.